Our Corporate Values

Strive for Good Science and Strong Processes

MMS is committed to making sound decisions based on strong scientific principles, internal expertise, and applicable regulation. As an organization, MMS emphasizes and values strong internal processes through defining, following, and improving upon the steps that lead to high-quality deliverables.

Value Talent – Find, Attract, Enhance and Retain

MMS recognizes that a talented staff is what drives our business forward. Identifying and attracting top talent and continual training to strengthen core skills are essential to core mission. At MMS, enthusiasm, collaboration, and teamwork is fostered, knowing that a global and diverse talent pool makes the company stronger.

Wow the Customer

MMS believes in delivering value beyond the competition. Each sponsor and researcher that MMS partners with is important and their goals relevant. MMS will strive to exceed their expectations by maintaining a customer focus throughout the project lifecycle, ensuring the customer experience is positive, building trust and forging long-term relationships.

Bring a Sense of Urgency and Leadership (SOUL)

MMS promotes the importance of SOUL through a healthy work environment and as a requirement for providing added value to clients. The SOUL of MMS comes to life as project work is completed on time and as risks and solutions are identified proactively. At MMS, each colleague takes responsibility for the success of every project.

“MMS does a great job of supporting colleague development through extensive training, job shadowing, mentoring, and teamwork activities.”
TEAM LEAD ON MENTORING

Suggested For You

news

March 19th, 2025

MMS REMS-focused Technology bolsters Full-Service REMS Solutions

webinar

April 30th, 2025

Advancing Clinical Development with Innovative Trial Design and Regulatory Strategies

perspectives

March 6th, 2025

Overview of FDA Guidance for Industry on Assessment of Ovarian Toxicity in Premenopausal Adults During Development for Oncologic Products

webinar

March 25th, 2025

Overcoming NDA/BLA Submission Challenges: Practical Strategies for Success

perspectives

February 13th, 2025

Helping European Drug Development Companies Succeed in the US Market

news

February 12th, 2025

MMS Acquires Exploristics and KerusCloud Simulation Platform to Expand Biostatistics and Data Science Capabilities as a Global Data-Focused CRO

perspectives

January 30th, 2025

Post-PDUFA VII Updates: FDA Meetings Public Workshop & Lessons Learned

perspectives

January 21st, 2025

REMS Modifications and Revisions: A Retrospective from the Past 12 Months

regulatory intelligence

January 17th, 2025

The FDA’s AI Guidance and its Seven Steps into the Future of Drug Development

regulatory intelligence

January 17th, 2025

New FDA Protocol Deviation Guidance:  Planning for the Things That Don’t Go According to Plan

perspectives

January 9th, 2025

How to Create Efficiencies When Creating Simultaneous NDA and MAA Submissions for the FDA and EMA

perspectives

January 2nd, 2025

Informed Consent in Clinical Research: Understanding its Significance and Sponsor Obligations